These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20350411)

  • 1. Buruli ulcer lesions in HIV-positive patient.
    Kibadi K; Colebunders R; Muyembe-Tamfum JJ; Meyers WM; Portaels F
    Emerg Infect Dis; 2010 Apr; 16(4):738-9. PubMed ID: 20350411
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined local and vaginal therapy in Buruli ulcer].
    Milánkovits M
    Orv Hetil; 2010 Aug; 151(35):1434-5. PubMed ID: 20824910
    [No Abstract]   [Full Text] [Related]  

  • 3. New foci of Buruli ulcer, Angola and Democratic Republic of Congo.
    Kibadi K; Panda M; Tamfum JJ; Fraga AG; Longatto Filho A; Anyo G; Pedrosa J; Nakazawa Y; Suykerbuyk P; Meyers WM; Portaels F
    Emerg Infect Dis; 2008 Nov; 14(11):1790-2. PubMed ID: 18976574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buruli ulcer disease in Republic of the Congo.
    Marion E; Obvala D; Babonneau J; Kempf M; Asiedu KB; Marsollier L
    Emerg Infect Dis; 2014 Jun; 20(6):1070-2. PubMed ID: 24857328
    [No Abstract]   [Full Text] [Related]  

  • 5. Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease).
    Chauty A; Ardant MF; Adeye A; Euverte H; Guédénon A; Johnson C; Aubry J; Nuermberger E; Grosset J
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4029-35. PubMed ID: 17526760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Child case of Buruli ulcer successfully treated through a school-based skin survey project in Côte d'Ivoire.
    Yotsu RR; Murase C; N'guessan K; Yao A; Kouadio K; N'Golo DC; N'Guetta A; Akiyama M; Constance K; Vagamon B
    J Dermatol; 2020 Feb; 47(2):e64-e65. PubMed ID: 31729074
    [No Abstract]   [Full Text] [Related]  

  • 7. Compliance with antimicrobial therapy for buruli ulcer.
    Klis S; Kingma R; Tuah W; Stienstra Y; van der Werf TS
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6340. PubMed ID: 25225342
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to "compliance with antimicrobial therapy for buruli ulcer".
    Phillips RO; Sarfo FS; Abass MK; Frimpong M; Ampadu E; Forson M; Amoako YA; Thompson W; Asiedu K; Wansbrough-Jones M
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6341. PubMed ID: 25225343
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ghana: the experience in the land highly endemic for Buruli ulcer].
    Yotsu R
    Nihon Hansenbyo Gakkai Zasshi; 2012 Apr; 81(1-2):155-9. PubMed ID: 22586949
    [No Abstract]   [Full Text] [Related]  

  • 10. To Buruli or not to Buruli.
    Ho L; Cohn J; Comte E
    Trop Doct; 2013 Apr; 43(2):92. PubMed ID: 23796682
    [No Abstract]   [Full Text] [Related]  

  • 11. Buruli ulcer. A disabling infection.
    Prescrire Int; 2010 Nov; 19(110):261-2. PubMed ID: 21284361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buruli ulcer in an 18-day-old baby.
    Kiiza AM; Wood PB
    Trop Doct; 2012 Jan; 42(1):48. PubMed ID: 22080481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy.
    Klis S; Kingma RA; Tuah W; van der Werf TS; Stienstra Y
    Trop Med Int Health; 2016 Sep; 21(9):1191-6. PubMed ID: 27456068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease.
    Phillips RO; Sarfo FS; Abass MK; Abotsi J; Wilson T; Forson M; Amoako YA; Thompson W; Asiedu K; Wansbrough-Jones M
    Antimicrob Agents Chemother; 2014; 58(2):1161-6. PubMed ID: 24323473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe multifocal form of buruli ulcer after streptomycin and rifampin treatment: comments on possible dissemination mechanisms.
    Sopoh GE; Dossou AD; Brun LV; Barogui YT; Houézo JG; Affolabi D; Anagonou SY; Johnson RC; Kestens L; Portaels F
    Am J Trop Med Hyg; 2010 Aug; 83(2):307-13. PubMed ID: 20682873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study.
    Tuffour J; Owusu-Mireku E; Ruf MT; Aboagye S; Kpeli G; Akuoku V; Pereko J; Paintsil A; Bonney K; Ampofo W; Pluschke G; Yeboah-Manu D
    Am J Trop Med Hyg; 2015 Aug; 93(2):216-23. PubMed ID: 26055745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of Streptomycin-Rifampicin treatment of Buruli Ulcer in two Ghanaian districts.
    Iddrisah FN; Yeboah-Manu D; Nortey PA; Nyarko KM; Anim J; Antara SN; Kenu E; Wurapa F; Afari EA
    Pan Afr Med J; 2016; 25(Suppl 1):13. PubMed ID: 28149438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease.
    Guarner J
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29343539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and prevention of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: guideline update.
    O'Brien DP; Jenkin G; Buntine J; Steffen CM; McDonald A; Horne S; Friedman ND; Athan E; Hughes A; Callan PP; Johnson PD
    Med J Aust; 2014 Mar; 200(5):267-70. PubMed ID: 24641151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of rifampicin-streptomycin for treatment of Buruli ulcer: a systematic review.
    Tanywe A; Fernandez RS
    JBI Database System Rev Implement Rep; 2017 Jan; 15(1):119-139. PubMed ID: 28085731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.